IRDye® 800RS Carboxylate

Basic Information

structure
IRDye® 800RS Carboxylate
sodium 6-(2-((E)-2-((E)-3-((E)-2-(3,3-dimethyl-1-(4-sulfonatobutyl)indolin-2-yli...
918936-51-3
C46 H52 N2 O9 S2 • 2Na
887.02g / Mol
Cyanine
• Polyprotic molecular weight = 843.06 for mass spectrometry analysis • Near-infrared (NIR) fluorescent dye • Solubility: Water or DMSO • More hydrophobic and less salt-tolerant than IRDye® 800CW • Carboxylic acid for covalent attachment; supplied as disodium salt • Used for making optical probes for NIR fluorescence imaging • Tendency to self-quench via dye-stacking at higher labeling concentrations

References

1
Drug release kinetics, cell uptake, and tumor toxicity of hybrid VVVVVVKK peptide-assembled polylactide nanoparticles., DOI: 10.1016/j.ejpb.2012.12.012

Overview

770 nm
786 nm
Methanol
300000 M-1cm-1

Absorption

770 nm
300000 M-1cm-1
-

Emission

786 nm
no
-
-

More parameters

Methanol
-

spectra uploaded by Lael Cheung

Provide more Spectra

Quantum Yields


Lifetimes


Availabilities

Commercial
LI-COR Biosciences (USA & Worldwide Distributor Information)
http://www.licor.com/bio/services/custom_labeling/
biosales@licor.com
Commercial
LI-COR Biosciences GmBH (Germany, Austria, Switzerland, & France)
http://www.licor.com/bio/services/custom_labeling/
bio-eu@licor.com
Commercial
LI-COR Biosciences Ltd (UK, Ireland, Scandinavia, & Iceland)
http://www.licor.com/bio/services/custom_labeling/
bio-eu@licor.com
Commercial
Japan: M&S TechnoSystems, Inc.
http://www.mstechno.co.jp/
technosales@technosaurus.co.jp
Commercial
China: Gene Company Ltd.
http://www.genecompany.com/
sales@genehk.com
Commercial
South Korea: Dong Young Instruments Co., Ltd.
http://www.dongyoung.co.kr/sub/index.php
product@dongyoung.co.kr
Commercial
Australia: Millennium Science Pty. Ltd.
http://www.mscience.com.au/
sales@mscience.com.au
Commercial
India: Inkarp Instruments Pvt. Ltd.
http://inkarp.co.in/
info@inkarp.co.in

Applications

fluorescent labeling
Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
10.3109/10837450.2016.1163385